These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28247838)

  • 1. [Better use of the front-end deductible in the Netherlands; private contributions to expenditure, costs awareness or incentives for quality].
    van der Hijden EJ
    Ned Tijdschr Geneeskd; 2017; 161():D1392. PubMed ID: 28247838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deductibles in health insurance: can the actuarially fair premium reduction exceed the deductible?
    Bakker FM; van Vliet RC; van de Ven WP
    Health Policy; 2000 Sep; 53(2):123-41. PubMed ID: 10958993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans.
    Leopold C; Wagner AK; Zhang F; Lu CY; Earle CC; Nekhlyudov L; Ross-Degnan D; Wharam JF
    Breast Cancer Res Treat; 2018 Sep; 171(2):449-459. PubMed ID: 29855813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of reinsuring a deductible on pharmaceutical spending: A Dutch case study on low-income people.
    Non M; van Kleef R; van der Galiën O; Douven R
    Health Policy; 2019 Oct; 123(10):976-981. PubMed ID: 31378537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the framing of patient cost-sharing incentives matter? the effects of deductibles vs. no-claim refunds.
    Hayen AP; Klein TJ; Salm M
    J Health Econ; 2021 Dec; 80():102520. PubMed ID: 34537581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimum generosity levels in a competitive health insurance market.
    Remmerswaal M; Boone J; Douven R
    J Health Econ; 2023 Jul; 90():102782. PubMed ID: 37392721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient responsiveness to a differential deductible: empirical results from The Netherlands.
    van der Geest SA; Varkevisser M
    Eur J Health Econ; 2019 Jun; 20(4):513-524. PubMed ID: 30539335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How profitable is a voluntary deductible in health insurance for the consumer?
    van Winssen KP; van Kleef RC; van de Ven WP
    Health Policy; 2015 May; 119(5):688-95. PubMed ID: 25747511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deductibles and health care expenditures: empirical estimates of price sensitivity based on administrative data.
    van Vliet RC
    Int J Health Care Finance Econ; 2004 Dec; 4(4):283-305. PubMed ID: 15467406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk equalization and voluntary deductibles: a complex interaction.
    van Kleef RC; Beck K; van de Ven WP; van Vliet RC
    J Health Econ; 2008 Mar; 27(2):427-43. PubMed ID: 18178276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential determinants of deductible uptake in health insurance: How to increase uptake in The Netherlands?
    van Winssen KP; van Kleef RC; van de Ven WP
    Eur J Health Econ; 2016 Dec; 17(9):1059-1072. PubMed ID: 26613608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Among Low-Income Respondents With Diabetes, High-Deductible Versus No-Deductible Insurance Sharply Reduces Medical Service Use.
    Rabin DL; Jetty A; Petterson S; Saqr Z; Froehlich A
    Diabetes Care; 2017 Feb; 40(2):239-245. PubMed ID: 27956384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is a Refundable Deductible Insurance an advantage for the insured? a mathematical approach.
    Claramunt MM; Mármol M
    PLoS One; 2021; 16(2):e0247030. PubMed ID: 33596261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shifted deductibles for high risks: more effective in reducing moral hazard than traditional deductibles.
    van Kleef RC; van de Ven WP; van Vliet RC
    J Health Econ; 2009 Jan; 28(1):198-209. PubMed ID: 18996607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The introduction of deductibles for prescription drugs in a national health insurance: compulsory or voluntary?
    Bakker FM; van Vliet RC
    Health Policy; 1995 Jan; 31(1):53-65. PubMed ID: 10140363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-deductible health plans and the new risks of consumer-driven health insurance products.
    ; Johnson AD; Wegner SE
    Pediatrics; 2007 Mar; 119(3):622-6. PubMed ID: 17332218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing Health Care Financial Burden With an Alternative Measure of Unaffordability.
    Kielb ES; Rhyan CN; Lee JA
    Inquiry; 2017 Jan; 54():46958017732960. PubMed ID: 28975850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method to simulate incentives for cost containment under various cost sharing designs: an application to a first-euro deductible and a doughnut hole.
    Cattel D; van Kleef RC; van Vliet RCJA
    Eur J Health Econ; 2017 Nov; 18(8):987-1000. PubMed ID: 27844177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of employer-offered high-deductible plans on low-value spending in the privately insured population.
    Rabideau B; Eisenberg MD; Reid R; Sood N
    J Health Econ; 2021 Mar; 76():102424. PubMed ID: 33493781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Financial Burdens Of High-Deductible Plans.
    Abdus S; Selden TM; Keenan P
    Health Aff (Millwood); 2016 Dec; 35(12):2297-2301. PubMed ID: 27920319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.